I would laugh if they were able to steal this away from jnj...jnj has had plenty of opportunities to buy vrtx...their loss.
I'm sure JNJ does have a better idea of vrtx's valuation..I would still laugh my a ss off if Novartis beat them to the punch!
JNJ always is in the buying mood with all the cash in hand. The company has close partnership in developing the Herp C drug, it knows very well how much Vertex worth than all other comapny, also you and me.
"The company has close partnership in developing the Herp C drug"Herp C? Try *Hep* C - it's for hepatitis, not herpes.